Recent News

• 04.25.2025 - 2025 AUA Analyst Day
• 04.24.2025 - PROCEPT BioRobotics' Aquablation Therapy Spotlighted at 2025 AUA Annual Meeting Along with Expert-Led Workshops
• 04.24.2025 - Q1 2025 Procept BioRobotics Earnings Conference Call
• 04.24.2025 - PROCEPT BioRobotics Reports First Quarter 2025 Financial Results and Increases 2025 Revenue Guidance
• 04.10.2025 - PROCEPT BioRobotics® Announces Investor Event at 2025 AUA Annual Meeting at the Aria Resort in Las Vegas
• 03.24.2025 - WATER III Randomized-Controlled Trial Results Announced at European Association of Urology Comparing Aquablation® Therapy to Laser Enucleation
• 03.14.2025 - PROCEPT BioRobotics® Announces Investor Event at 2025 AUA Annual Meeting in Las Vegas, Nevada
• 03.11.2025 - Leerink Healthcare Conference

Recent Filings

• 04.24.2025 - 8-K Current report
• 04.24.2025 - EX-99.1 EX-99.1
• 04.11.2025 - 10-K/A Annual report [Section 13 and 15(d), not S-K Item 405]
• 03.19.2025 - 4 Statement of changes in beneficial ownership of securities
• 03.19.2025 - 4 Statement of changes in beneficial ownership of securities
• 03.19.2025 - 4 Statement of changes in beneficial ownership of securities
• 03.19.2025 - 4 Statement of changes in beneficial ownership of securities
• 03.18.2025 - 144 Report of proposed sale of securities
• 03.18.2025 - 144 Report of proposed sale of securities
• 03.18.2025 - 144 Report of proposed sale of securities